INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 125 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $74,000 | +42.3% | 13,320 | 0.0% | 0.01% | +37.5% |
Q2 2018 | $52,000 | -17.5% | 13,320 | 0.0% | 0.01% | -20.0% |
Q1 2018 | $63,000 | +14.5% | 13,320 | 0.0% | 0.01% | +11.1% |
Q4 2017 | $55,000 | -34.5% | 13,320 | 0.0% | 0.01% | -35.7% |
Q3 2017 | $84,000 | -19.2% | 13,320 | 0.0% | 0.01% | -22.2% |
Q2 2017 | $104,000 | +18.2% | 13,320 | 0.0% | 0.02% | +12.5% |
Q1 2017 | $88,000 | -4.3% | 13,320 | 0.0% | 0.02% | -11.1% |
Q4 2016 | $92,000 | -25.8% | 13,320 | 0.0% | 0.02% | -21.7% |
Q3 2016 | $124,000 | +0.8% | 13,320 | 0.0% | 0.02% | -4.2% |
Q2 2016 | $123,000 | +6.0% | 13,320 | 0.0% | 0.02% | +4.3% |
Q1 2016 | $116,000 | +28.9% | 13,320 | 0.0% | 0.02% | +27.8% |
Q4 2015 | $90,000 | +16.9% | 13,320 | 0.0% | 0.02% | +5.9% |
Q3 2015 | $77,000 | -29.4% | 13,320 | 0.0% | 0.02% | -26.1% |
Q2 2015 | $109,000 | 0.0% | 13,320 | 0.0% | 0.02% | +4.5% |
Q1 2015 | $109,000 | -10.7% | 13,320 | 0.0% | 0.02% | -4.3% |
Q4 2014 | $122,000 | -6.9% | 13,320 | 0.0% | 0.02% | -11.5% |
Q3 2014 | $131,000 | – | 13,320 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Round Table Services, LLC | 129,500 | $1,207,000 | 0.72% |
STONERIDGE INVESTMENT PARTNERS LLC | 252,376 | $2,352,000 | 0.34% |
Bellevue Group AG | 155,000 | $1,445,000 | 0.26% |
WASATCH ADVISORS LP | 1,861,553 | $17,350,000 | 0.26% |
Blue Clay Capital Management, LLC | 13,000 | $121,000 | 0.14% |
Virtus ETF Advisers LLC | 24,058 | $224,000 | 0.11% |
EMERALD ADVISERS, LLC | 203,737 | $1,899,000 | 0.08% |
Vident Investment Advisory, LLC | 63,383 | $591,000 | 0.08% |
Thomas J. Herzfeld Advisors, Inc. | 15,000 | $140,000 | 0.08% |
GSA CAPITAL PARTNERS LLP | 94,400 | $880,000 | 0.05% |